AVAH · Aveanna Healthcare Holdings, Inc. · Documents

$11.50 -0.74 (-6.05%) At close · Nov 13 Play latest call Q2 2026 earnings call transcript

Russell 2000 member Rebalance outlook locked

Market Cap

$2.51B

218.41M

Volume · Nov 13 4.27M Avg daily vol (3M) 3.01M

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

2023

May 11

Current report 8-K

Financial results, Regulation FD disclosure

May 11

Quarterly report 10-Q FY2023 Q1, ended Apr 1

Quarterly report for FY2023 Q1

Revenue $466.41M ▲ 3.5% Net loss $32M Diluted EPS -$0.17

Mar 31

Proxy statement DEF 14A Meeting May 10, 2023

Proxy statement

Mar 31

Annual report to holders ARS

Annual report to holders

Mar 31

Proxy statement DEFA14A

Proxy statement

Mar 17

Proxy statement PRE 14A Meeting May 10, 2023

Proxy statement

Mar 16

Earnings call

Q4 2022 earnings call

Mar 16

Current report 8-K

Financial results, Regulation FD disclosure

Mar 16

Annual report 10-K FY2022, ended Dec 31

Annual report for FY2022

Revenue $1.79B ▲ 6.5% Net loss $662.03M Diluted EPS -$3.57

2022

Dec 27

Current report 8-K Events of Dec 23

Delisting notice or listing transfer

Dec 23

Current report 8-K/A Events of May 10

Shareholder vote results

Dec 13

Current report 8-K Events of Dec 7

Director or officer change, or executive pay, Regulation FD disclosure

Nov 15

Quarterly report 10-Q FY2022 Q3, ended Oct 1

Quarterly report for FY2022 Q3

Revenue $443.01M ▲ 7.7% Net income $24.3M ▲ 1062.6% Diluted EPS $0.13 ▲ 1200.0%

Nov 9

Earnings call

Q3 2022 earnings call

Nov 9

Current report 8-K

Financial results, Regulation FD disclosure

Aug 11

Current report 8-K Events of Aug 10

Financial results, Regulation FD disclosure

Aug 11

Quarterly report 10-Q FY2022 Q2, ended Jul 2

Quarterly report for FY2022 Q2

Revenue $442.96M ▲ 1.6% Net loss $473.89M Diluted EPS -$2.56

Jul 19

Current report 8-K

Financial results, Regulation FD disclosure

Jun 30

Earnings call

Q2 2022 earnings call

May 16

Current report 8-K Events of May 10

Shareholder vote results

May 11

Earnings call

Q1 2022 earnings call

May 11

Current report 8-K

Financial results, Regulation FD disclosure

May 11

Quarterly report 10-Q FY2022 Q1, ended Apr 2

Quarterly report for FY2022 Q1

Revenue $450.53M ▲ 8.0% Net income $25.33M ▲ 336.9% Diluted EPS $0.14 ▲ 250.0%

Apr 27

Current report 8-K

Regulation FD disclosure

Mar 30

Proxy statement DEF 14A Meeting May 10, 2022

Proxy statement

Mar 30

Proxy statement DEFA14A

Proxy statement

Mar 28

Earnings call

Q4 2021 earnings call

Mar 28

Current report 8-K

Financial results, Regulation FD disclosure

Mar 28

Annual report 10-K FY2021, ended Jan 1

Annual report for FY2021

Revenue $1.68B ▲ 12.3% Net loss $117.04M

Feb 25

Current report 8-K/A Events of Dec 10

Current report

2021

Dec 16

Current report 8-K Events of Dec 10

Entered into a material agreement, Completed an acquisition or sale of assets, New debt or off-balance-sheet obligation

Dec 3

Current report 8-K Events of Nov 30

Other events

Nov 29

Current report 8-K

Regulation FD disclosure

Nov 15

Earnings call

Q3 2021 earnings call

Nov 15

Current report 8-K

Financial results, Regulation FD disclosure

Nov 15

Quarterly report 10-Q FY2021 Q3, ended Oct 2

Quarterly report for FY2021 Q3

Revenue $411.28M ▲ 12.4% Net income $2.09M Diluted EPS $0.01

Oct 1

Current report 8-K Events of Sep 27

Entered into a material agreement

Aug 23

Current report 8-K

Regulation FD disclosure

Aug 11

Earnings call

Q2 2021 earnings call

Aug 11

Current report 8-K

Financial results, Regulation FD disclosure

Aug 11

Quarterly report 10-Q FY2021 Q2, ended Jul 3

Quarterly report for FY2021 Q2

Revenue $436.11M ▲ 24.0% Net income $1.26M Diluted EPS $0.01

Jul 20

Current report 8-K Events of Jul 15

Entered into a material agreement

May 25

Earnings call

Q1 2021 earnings call

May 25

Current report 8-K

Financial results, Regulation FD disclosure

May 25

Quarterly report 10-Q FY2021 Q1, ended Apr 3

Quarterly report for FY2021 Q1

Revenue $417.16M ▲ 17.4% Net income $5.8M ▼ 84.6% Diluted EPS $0.04 ▼ 85.2%

May 19

Current report 8-K Events of May 13

Director or officer change, or executive pay

May 5

Current report 8-K Events of May 3

Ended a material agreement, Other events

Apr 28

Registration statement S-1/A

Registration statement

Apr 26

Registration statement S-1/A

Registration statement

Apr 20

Registration statement S-1/A

Registration statement

Showing 101–150 of 151 documents

Key facts CIK 1832332 CUSIP 05356F105 13F (30d) 187 filings 172 filers Visit website Investor relations